Developing vaccines against epidemic-prone emerging infectious diseases
Bernasconi, V.; Kristiansen, P.A.; Whelan, M.; Román, R.G.; Bettis, A.; Yimer, S.A.; Gurry, C.; Andersen, S.R.; Yeskey, D.; Mandi, H.; Kumar, A.; Holst, J.; Clark, C.; Cramer, J.P.; Røttingen, J.; Hatchett, R.; Saville, M.; Norheim, G. · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · 2019 · Heft 11 · S. 65 bis 73
Bibliografische Angaben
Zusammenfassung
BackgroundGlobal trends, including increasing population density, urbanization, human mobility, and climate and ecological change, are leading to emerging infectious diseases (EIDs) that pose a growing threat to global health security [1]. If a highly contagious and lethal airborne pathogen with the characteristics of the 1918 pandemic influenza were to emerge today, it is estimated that nearly 33 million people might die in just 6 months worldwide [2].The costs of EIDs are enormous, both in terms of lives lost and economic burden. A report prepared by the U.S. National Academy of Sciences in 2016 estimated that…
